GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Entheon Biomedical Corp (XCNQ:ENBI) » Definitions » Equity-to-Asset

Entheon Biomedical (XCNQ:ENBI) Equity-to-Asset

: 0.79 (As of Nov. 2023)
View and export this data going back to 2018. Start your Free Trial

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Entheon Biomedical's Total Stockholders Equity for the quarter that ended in Nov. 2023 was C$0.32 Mil. Entheon Biomedical's Total Assets for the quarter that ended in Nov. 2023 was C$0.40 Mil.

The historical rank and industry rank for Entheon Biomedical's Equity-to-Asset or its related term are showing as below:

XCNQ:ENBI' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.67   Med: 0.8   Max: 0.98
Current: 0.79

During the past 7 years, the highest Equity to Asset Ratio of Entheon Biomedical was 0.98. The lowest was 0.67. And the median was 0.80.

XCNQ:ENBI's Equity-to-Asset is ranked better than
66.09% of 1566 companies
in the Biotechnology industry
Industry Median: 0.66 vs XCNQ:ENBI: 0.79

Entheon Biomedical Equity-to-Asset Historical Data

The historical data trend for Entheon Biomedical's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Entheon Biomedical Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Nov21 Nov22 Nov23
Equity-to-Asset
Premium Member Only Premium Member Only 0.98 0.98 0.91 0.80 0.79

Entheon Biomedical Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23
Equity-to-Asset Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.80 0.78 0.85 0.90 0.79

Competitive Comparison

For the Biotechnology subindustry, Entheon Biomedical's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Entheon Biomedical Equity-to-Asset Distribution

For the Biotechnology industry and Healthcare sector, Entheon Biomedical's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Entheon Biomedical's Equity-to-Asset falls into.



Entheon Biomedical Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Entheon Biomedical's Equity to Asset Ratio for the fiscal year that ended in Nov. 2023 is calculated as

Equity to Asset (A: Nov. 2023 )=Total Stockholders Equity/Total Assets
=0.316/0.401
=0.79

Entheon Biomedical's Equity to Asset Ratio for the quarter that ended in Nov. 2023 is calculated as

Equity to Asset (Q: Nov. 2023 )=Total Stockholders Equity/Total Assets
=0.316/0.401
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Entheon Biomedical  (XCNQ:ENBI) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Entheon Biomedical Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Entheon Biomedical's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Entheon Biomedical (XCNQ:ENBI) Business Description

Traded in Other Exchanges
Address
999 West Broadway Street, Suite 720, Vancouver, BC, CAN, V5Z 1K5
Entheon Biomedical Corp is a biotechnology research and development company committed to developing and commercializing a portfolio of safe and effective Dimethyltryptamine based psychedelic therapeutic products (DMT Products) for the purposes of treating addiction and substance use disorders. Entheon intends to generate revenue through the sale of its DMT Products to physicians, clinics, and licensed psychiatrists in the United States, certain countries in the European Union, and throughout Canada.

Entheon Biomedical (XCNQ:ENBI) Headlines

No Headlines